Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.
Clinical trial NCT05358106 · COMPLETED
Trial details
- NCT number
- NCT05358106
- Sponsor
- Memo Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2022-12-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.